← SynDRA
PROBUCOL
SynDRA canonical compound SYN0001138 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · OTC |
| Primary target(s) | ABCA1 |
| Mechanism of action | Atherogenesis inhibitor |
| Indication | coronary artery disease (CAD) |
| Disease area | cardiology |
All known targets
- ABCA1
- ABCB11
- ALOX15
- CES1
- HPN
- KCNH2
- SIRT5
Mechanisms of action (all sources)
- Atherogenesis inhibitor
- ABCA1 INHIBITOR
- ATP-binding cassette sub-family A member 1 inhibitor
- ABCA1 MODULATOR
Drug classes
- Anticholesteremic Agents
- Antimetabolites
- Antioxidants
- Hypolipidemic Agents
- Lipid Regulating Agents
- Protective Agents
ATC classes
- C10A · LIPID MODIFYING AGENTS, PLAIN
Cross-references
Synonyms
- biphenabid
- bisphenabid
- phenbutol
- lorelco
- DH-581
- NSC-652160
- NSC-86225
- Bisbid
- Lorelco
- Lurselle
- Sinlestal
- Biphenabid
- Bisphenabid
- Lesterol
- Lursell
- Panavir
- Probucolum
- Superlipid
- Almirall Brand of Probucol
- Aventis Brand of Probucol
- Hoechst Brand of Probucol
- DH581
- DE-3872
- LORELCO (TN)
- Probucolum [INN-Latin]
- ZERO/001429
- Probucol (JAN/USP/INN)
- Probucol [USAN:BAN:INN:JAN]
- Acetone bis(3,5-di-tert-butyl-4-hydroxyphenyl) mercaptole
- Acetone, bis (3,5-di-tert-butyl-4-hydroxyphenyl) mercaptole
- Acetone, bis(3,5-di-tert-butyl-4-hydroxyphenyl) mercaptole
- 2,6-ditert-butyl-4-[2-(3,5-ditert-butyl-4-hydroxyphenyl)sulfanylpropan-2-ylsulfanyl]phenol
- 4,4'-(Isopropylidenedithio)bis(2, 6-di-tert-butylphenol)
- 4,4'-(Isopropylidenedithio)bis(2,6-di-tert-butylphenol)
- 4,4'-(Isopropylidenedithio)bis[2, 6-di-tert-butylphenol]
- 4,4'-(Isopropylidenedithio)bis[2,6-di-tert-butylphenol]
- 4,4'-(propane-2,2-diyldisulfanediyl)bis(2,6-di-tert-butylphenol)
- 4,4'-[(1-Methylethylidene)bis(thio)]bis-[2,6-bis(1,1-dimethylethyl)phenol]
Look up PROBUCOL in the interactive SynDRA portal →